BridgeMD
Tests treatment safety and results for Fatigue Syndrome, Chronic
Official title Effectiveness of Acceptance Commitment Therapy or Micro Breaks in Patients with Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis
ClinicalTrials.gov ID: NCT05168124
What this study is testing
- What it's testing
- Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a distinct disease entity with an estimated prevalence of 0.3-0.7% and more common in women (3:1 ratio). It can be diagnosed according to the Institute of Medicine (IOM) 2015 consensus definition using 3 major criteria and one of 2 minor criteria.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Diagnosis for CFS/ME
- Psychiatric clinical stability in the past 3 months:
- No diagnostic change to other categories of the International Classification of Diseases (ICD-10)
- No psychiatric inpatient treatments
- No psychiatric emergency treatments
You likely can't join if
- Insufficient knowledge of German
- Severe psychiatric disorders (e.g. personality and posttraumatic stress disorders, dissociative and psychotic disorders, intelligence reduction...
- Untreated or severe internal medicine disorders e.g., thyroid dysfunction, central and obstructive sleep apnea syndrome (i.e., apnea-hypopnea index...
- Cardiovascular disease such as chronic heart failure
- Severe or untreated neurological diseases (e.g. Parkinson's disease, dementia, restless legs syndrome, narcolepsy)
- Alcohol and drug dependence
See the full eligibility criteria
- Diagnosis for CFS/ME
- Psychiatric clinical stability in the past 3 months:
- No diagnostic change to other categories of the International Classification of Diseases (ICD-10)
- No psychiatric inpatient treatments
- No psychiatric emergency treatments
- No suicide attempts
- Possession of internet access
- Sufficient skills to use electronic devices
- The willingness to engage in the described therapeutic procedures or interventions (ACT, MBEL)
- Insufficient knowledge of German
- Severe psychiatric disorders (e.g. personality and posttraumatic stress disorders, dissociative and psychotic disorders, intelligence reduction, untreated attention deficit hyperactivity disorder) and acute suicidal...
- Untreated or severe internal medicine disorders e.g., thyroid dysfunction, central and obstructive sleep apnea syndrome (i.e., apnea-hypopnea index \>15 and/or "high-risk group for obstructive sleep apnea" according to...
- Cardiovascular disease such as chronic heart failure
- Severe or untreated neurological diseases (e.g. Parkinson's disease, dementia, restless legs syndrome, narcolepsy)
- Alcohol and drug dependence
- Initiation of psychopharmacotherapy at a dosage provided for guideline-appropriate treatment of a mental disorder according to the Drug Compendium in the past 3 months
- Start of other psychotherapy procedures in the last 3 months
- Other parallel therapy methods (e.g. acupuncture, qigong, osteopathy)
- Somatic (sleep-disrupting) treatments, cortisone treatment, or radio-/chemotherapy in the last 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Zurich, Switzerland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.